K. Winter

RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma

William F. Regine, K. Winter, Ross A. Abrams et al. · Journal of Clinical Oncology · 2006 · 101 citations

Adjuvant 5-Fu Crt, Surgical Oncology, G Arm +14

A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: initial outcomes of RTOG 9517

Robert R. Kuske, K. Winter, D.W. Arthur et al. · Journal of Clinical Oncology · 2004 · 45 citations

Surgical Oncology, Breast Oncology, Surgery +23

Androgen suppression adjuvant to radiotherapy in carcinoma of the prostate. long-term results of phase III RTOG study 85-31

M.V. Pilepich, K. Winter, C.A. Lawton et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 33 citations · Full text

Urology, Radiation Medicine, Androgen Suppression Adjuvant +8

Acute and late toxicity results of RTOG 9311: a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer

Jeffrey D. Bradley, Mary V. Graham, K. Winter et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 27 citations · Full text

Radiation Therapy, Conformal Radiation Therapy, Rtog 9311 +8

RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer

Stuart J. Wong, K. Winter, Neal J. Meropol et al. · Journal of Clinical Oncology · 2008 · 19 citations

Surgical Oncology, Rtog 0247, Radiation Therapy +15